About RISE Registry
Rheumatology Informatics System for Effectiveness (RISE) is the first and largest electronic health record (EHR)-enabled rheumatology registry in the United States.
A CMS-approved Clinical Quality Data Registry (QCDR), RISE attracts widespread participation among rheumatology clinicians and providers. With over 1,000 rheumatology clinicians and 3.8 million patients, RISE is instrumental in advancing the specialty through improving care and expanding research.
The RISE registry was developed by the ACR in 2014 to help clinicians and researchers:
- Optimize patient outcomes
- Navigate the Quality Payment Program (QPP) Merit-based Incentive Payment System (MIPS) and MIPS Value Pathway (MVP) reporting requirements
- Make discoveries that advance rheumatology
- Demonstrate the value of rheumatology to key influencers through advocacy, etc.
New in 2026: Enhanced RISE Platform
The new RISE platform offers state-of-the-art user experience, comprehensive insights, simplified federal (QPP) reporting, and a modern, intuitive dashboard designed to support continuous quality improvement.
RISE for Performance
RISE helps rheumatology and health care providers assess their quality of patient care and identify improvement opportunities. With national and RISE benchmarks for easy comparison, clinicians use the RISE dashboard to track performance down to the individual patient level. Using RISE’s rheumatology-specific QCDR measures, you can evaluate and track improvements in your patient care over time.
RISE for PerformanceRISE for Discovery
RISE offers unique opportunities for research and analysis by providing a rich collection of data on patients with rheumatic diseases. As a rheumatology-specific registry, RISE includes patients with all conditions seen by a rheumatologist and all insurance types. It also provides detailed information on patient demographics and clinical characteristics.
RISE for DiscoveryRISE Information
See additional information to optimize your RISE registry experience.